There are currently no press releases for this ticker. Please check back later.
Carmat is medical technology start-up company. The Company intends to market a fully implantable artificial heart for patients suffering in the aftermath of a heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible.
36 avenue de l'Europe CS 40533 - Immeuble l'Etendard Velizy Villacoublay Cedex, 78941 France